Table 4.
Accumulation of BCP mutations among patients with HCC and CH in context of HBeAg
| Mutation | HBeAg-positive group | HBeAg-negative group | ||||
|---|---|---|---|---|---|---|
|
| ||||||
| HCC (n=70) | CH (n=74) | P value | HCC (n=32) | CH (n=31) | P value | |
| T1762/A1764 | 46 (65.7%) | 40 (54.1%) | 0.891 | 20 (62.5%) | 14 (45.2%) | 0.634 |
| V1753/T1762/A1764 | 10 (14.3%)* | 3 (4.1%) | 0.027 | 2 (6.3%) | 1 (3.2%) | 0.062 |
| T1762/A1764/A1768 | 6 (8.6%)* | 2 (2.7%) | 0.031 | 1 (3.1%) | 1 (3.2%) | 0.961 |
| V1753/T1762/A1764/A1768 | 3 (4.3%)* | 1 (1.4%) | 0.041 | 0 (0%) | 0 (0%) | |
HCC vs. CH, P<0.05 (Yates corrected chi-square).
Significant data are shown in bold.